Justin W. Yorke - Mar 15, 2022 Form 4 Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role
Director
Signature
/s/ Justin W. Yorke by Michael B. Kirwan, as Attorney-in-Fact
Stock symbol
PCSA
Transactions as of
Mar 15, 2022
Transactions value $
$0
Form type
4
Date filed
4/19/2022, 09:20 PM
Previous filing
Jan 31, 2022
Next filing
Apr 4, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCSA Restricted Stock Award $0 +18.2K +1557.57% $0.00 19.4K Jan 1, 2022 Common Stock 18.2K $0.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units vest 100% on December 31, 2022.